Spirax Group (SPX) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
11 Nov, 2026Group performance and outlook
Organic sales growth and adjusted operating profit margin for the 10 months to October were in line with expectations and ahead of H1; Together for Growth continued to drive growth.
FY guidance reaffirmed: mid-single-digit organic Group revenue growth and adjusted operating profit margin above the 2025 level of 20.0%.
STS FY margin expected broadly in line with 2025; medium-term targets set in 2024 remain on track.
FY cash conversion expected at ~90%.
Segment trading
STS organic sales growth accelerated in the four months to October, supported by June-end orderbook shipments and continued order momentum; H2 margin expected ahead of H1.
STS China MRO growth is double-digit; large-project declines are moderating, and China sales are on track to match 2025 for the full year.
ETS sustained strong H1 organic sales growth; Process Heating and Heat Trace order intake remained strong, and Equipment Heating benefited from higher Semicon demand. Growth excluding Semicon remains above the mid-single-digit medium-term target.
ETS operational gearing and manufacturing efficiencies are expected to support a higher H2 margin than H1.
WMFTS Biopharm and Process Industries sales growth strengthened; orders remained ahead of Biopharm sales, with H2 growth expected to lift margin slightly above H1.
Financial position
Net borrowings excluding leases were £541.6m at 31 October, down from £618.2m at 30 June; net debt to EBITDA was 1.3x, versus 1.6x.
Latest events from Spirax Group
- Organic growth and margin expansion drive strong H1 results and support full-year outlook.SPX
H1 2026 - Mid-single-digit organic growth and margin improvement expected for 2026.SPX
Trading update - Organic sales and profit rose, margins improved, and cash conversion reached 89% with a strong 2026 outlook.SPX
H2 2025 - Organic growth and margin ahead of H1, with full year outlook reaffirmed and net debt reduced.SPX
Trading update - Organic growth and margin expansion support an unchanged full-year outlook despite headwinds.SPX
H1 2025 - Decarbonization, digitalization, and operational excellence drive growth and margin expansion.SPX
CMD 2024 - Organic sales growth ahead of H1; full year outlook unchanged despite increased currency headwinds.SPX
Trading Update - Organic sales up, reported revenue down; full-year growth and margin stability expected.SPX
H1 2024 - Organic growth outpaced industrial production, with margin stability and a 3% dividend increase.SPX
H2 2024